MarketBeat
01 Aug 2026, 03:05 UTC · 2h ago
Stryker Q2 Earnings Call Highlights
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
MarketBeat
01 Aug 2026, 03:05 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
Stryker reported 9% organic sales growth and 17.9% adjusted EPS growth for Q2 2026. — Strong top and bottom line growth beats suggest robust demand and efficient operational execution.
+0.60The company narrowed its full-year organic net sales growth guidance to 8.3% to 9.3% and adjusted EPS to $14.95 to $15.10. — Providing a tighter, positive outlook reduces uncertainty and confirms growth trajectory for the year.
+0.50Adjusted operating margins increased by 170 basis points to 27.4% of sales. — Margin expansion indicates improved profitability and effective cost management despite external headwinds.
+0.40U.S. vascular organic sales declined 6.7% due to an operational disruption in the Peripheral Vascular business. — A specific business segment decline due to supply issues creates a short-term drag on overall growth.
Continue reading
6 related stories
Top 1 mover · tap to explore
Mako robotic installations achieved record second-quarter levels in both U.S. and international markets. — Strong adoption of high-value robotics drives long-term recurring revenue and competitive advantage.
+0.30Which stocks this story touches
Strong Q2 organic sales and EPS growth, recovery from cybersecurity issues, and record Mako installations.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
MarketBeat
1h ago
